World Journal of Diabetes (WJD, World J Diabetes) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing clinical, basic, and translational research achievements that are innovative, novel, and practical in the fields of diabetes. The types of articles published in WJD include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. WJD is edited and published by the Baishideng Publishing Group.

The primary aim of WJD is to provide scholars and readers from various fields of diabetes with a platform for publishing high-quality clinical, basic, and translational research achievements. In order to ensure the quality, fairness, and transparency of publication, WJD has implemented a variety of measures, as follows: 

1 Academic norms and ethical requirements. Adherence to both academic norms and ethical requirements is closely related to peer review and first-decision making for the manuscript. Authors are recommended to prepare their articles according to the appropriate international publication recommendations, including the STROBE Statement, CONSORT 2010 Statement, PRISMA 2009 Checklist, and CARE Checklist – 2016: Information for writing a case report. For all articles involving human studies, organ transplantations, and/or animal experiments, before their acceptance, author(s) must provide the related formal ethics documents that were reviewed and approved by their local ethical review committee. For full guidelines for authors, please visit: https://www.wjgnet.com/bpg/gerinfo/204.

2 Peer-review process. Articles published in WJD must undergo rigorous external, single-blind peer review. For the full peer-review process, please visit: https://www.wjgnet.com/bpg/gerinfo/241.

3 Designation of co-first authors and/or co-corresponding authors. Designation of co-first authors and/or co-corresponding authors is permitted. For the policy of allowing co-first authors and co-corresponding authors who made equal contribution to a manuscript, please visit: https://www.wjgnet.com/bpg/GerInfo/310.

4 Publication of innovative original articles. WJD's acceptance of a manuscript for publication is based on its novelty, innovativeness, data accuracy, image reliability, clear language expression, and ethical requirements. 

5 Disclosure of documents related to the article. The peer review report, author response to the peer review report, biostatistics review certificate, copyright license agreement, institutional ethics committee approval document, informed consent document(s), conflict-of-interest statement, CrossCheck detection report, corresponding author(s) personal ORCID number(s), funding information, language editing certificate, and other relevant documents will be published online along with the article to allow for an open and transparent publishing process.

The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJD as 4.6; JIF without journal self cites: 4.3; 5-year JIF: 5.0; JIF Rank: 43/191 in endocrinology and metabolism; JIF Quartile: Q1; and 5-year JIF Quartile: Q1.